Slide Decks

Dementia is an umbrella term used to describe a state where an individual has lost the ability to carry out daily life activities independently because of cognitive impairment that is not due to an underlying psychiatric condition. Alzheimer’s disease (AD) refers to the abnormal presence of Aβ and tau proteins, which define AD among many other neurodegenerative diseases. Dementia -including dementia due to AD- is likely to be underestimated because of underdiagnosis and misdiagnosis.

This slide deck summarizes the current knowledge surrounding the use of psychedelics for the treatment of depression. Specifically, our focus centers on serotonergic psychedelics, commonly referred to as classical psychedelics. These psychedelics primarily function as agonists or partial agonists at the serotonin 2A receptor (5-HT2A receptor).

In this slide deck you will find basic concepts and definitions related to approaches such as disease-stage-specific treatment and psychosocial therapies. The slide deck also offers a brief introduction to general considerations for managing Alzheimer’s disease.

This slide deck discusses the epidemiology and burden of Alzheimer’s disease (AD) and highlights topics as prevalence of dementia, burden of AD and the assessment scales for the quality of life and resource utilization in dementia.

This slide deck describes current knowledge on the the physical and psyciatric comorbidites of Alzheimer’s disease (AD).

This slide deck discusses in detail the course, natural history and prognosis of Alzheimer´s disease (AD), with illustrations.